ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,532,607 | -11.6% | 85,382 | 0.0% | 0.05% | -8.9% |
Q2 2023 | $1,734,108 | +11.3% | 85,382 | 0.0% | 0.06% | +5.7% |
Q1 2023 | $1,557,368 | -11.6% | 85,382 | +0.3% | 0.05% | -30.3% |
Q4 2022 | $1,761,047 | -20.7% | 85,157 | +0.3% | 0.08% | -25.5% |
Q3 2022 | $2,220,000 | +3.3% | 84,862 | +0.0% | 0.10% | +3.0% |
Q2 2022 | $2,150,000 | -24.1% | 84,857 | +0.0% | 0.10% | -11.6% |
Q1 2022 | $2,833,000 | -17.5% | 84,828 | +0.0% | 0.11% | -11.8% |
Q4 2021 | $3,432,000 | +15.8% | 84,803 | -0.2% | 0.13% | +6.7% |
Q3 2021 | $2,963,000 | +26.6% | 84,983 | -0.3% | 0.12% | +20.2% |
Q2 2021 | $2,340,000 | -2.2% | 85,225 | 0.0% | 0.10% | -12.4% |
Q1 2021 | $2,393,000 | +8.2% | 85,225 | 0.0% | 0.11% | -5.8% |
Q4 2020 | $2,212,000 | +51.4% | 85,225 | 0.0% | 0.12% | +33.3% |
Q3 2020 | $1,461,000 | -32.0% | 85,225 | -1.9% | 0.09% | -35.7% |
Q2 2020 | $2,149,000 | +76.7% | 86,880 | -0.8% | 0.14% | +42.9% |
Q1 2020 | $1,216,000 | +38.7% | 87,614 | +0.9% | 0.10% | +48.5% |
Q4 2019 | $877,000 | +12.0% | 86,855 | +0.9% | 0.07% | -1.5% |
Q3 2019 | $783,000 | +15560.0% | 86,055 | +13668.8% | 0.07% | – |
Q2 2019 | $5,000 | – | 625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |